Machine Learning in Materials Science
Evidence window ending 2026-05-25
Machine Learning in Materials Science shows 1,265 eligible recent papers and 1,262 commentary-ready papers in the current 30-day window, compared with 1,018 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.
Quantum Computing Algorithms and Architecture
Evidence window ending 2026-05-25
Quantum Computing Algorithms shows 849 eligible recent papers and 848 commentary-ready papers in the current 30-day window, compared with 699 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.
Computational Drug Discovery Methods
Evidence window ending 2026-05-25
Computational Drug Discovery shows 613 eligible recent papers and 613 commentary-ready papers in the current 30-day window, compared with 485 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.
Explainable Artificial Intelligence (XAI)
Evidence window ending 2026-05-25
Explainable AI shows 1,508 eligible recent papers and 1,508 commentary-ready papers in the current 30-day window, compared with 1,285 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.
Smart Agriculture and AI
Evidence window ending 2026-05-25
Smart Agriculture and AI shows 704 eligible recent papers and 704 commentary-ready papers in the current 30-day window, compared with 674 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.
Sepsis Diagnosis and Treatment
Evidence window ending 2026-05-25
Sepsis Diagnosis and Treatment shows 724 eligible recent papers and 721 commentary-ready papers in the current 30-day window, compared with 559 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.
Dementia and Cognitive Impairment Research
Evidence window ending 2026-05-25
Dementia and Cognitive Impairment shows 689 eligible recent papers and 687 commentary-ready papers in the current 30-day window, compared with 586 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.
Gut microbiota and health
Evidence window ending 2026-05-25
Gut Microbiota and Health shows 1,104 eligible recent papers and 1,100 commentary-ready papers in the current 30-day window, compared with 904 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.
